Physician profile
Michael E Goldsmith
NPI 1588755854
$70,157.03
in general payments reported to CMS, 2019-2025
14 companies · $8,459 in 2025
The $8,459 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $12K · 2021: $9,877 · 2022: $7,617 · 2023: $9,328 · 2024: $7,119 · 2025: $8,459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $19K · Consulting Fee: $3,975 · Food and Beverage: $1,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $19,076.45 |
| Consulting Fee | $3,975.00 |
| Food and Beverage | $1,855.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $66,574.61 | 2019-2025 | Magnify-S / Magnify, Magnify, Simplify Cervical Artificial Disc |
| Locate Bio INC | $1,125.00 | 2025 | Ldgraft |
| Nuvasive, INC. | $1,050.00 | 2023 | Simplify Cervical Artificial Disc |
| Medtronic, INC. | $753.82 | 2021-2025 | Aquamantys(Tm), Catalyft Pl Expandable Interbody System |
| Medtronic USA, INC. | $303.41 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $83.83 | 2019-2020 | |
| Cerapedics INC. | $72.54 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Seaspine Orthopedics Corporation | $57.40 | 2021 | |
| Woven Orthopedic Technologies, LLC | $34.47 | 2024 | |
| Providence Medical Technology, INC. | $26.76 | 2021 | |
| Djo, LLC | $23.45 | 2022 | |
| Medtronic Vascular, INC. | $19.26 | 2020 | |
| Fidia Pharma USA INC. | $17.53 | 2022 | |
| Misonix INC | $14.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$97,888.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Goldsmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.